Clinical evidence suggests that retatrutide achieves durable weight loss, which is crucial for lasting health gains
25-39% The estimated proportion of weight lost on GLP-1 therapy that may come from lean mass rather than fat, based on body composition analyses from clinical trial data. The precise figure varies by patient, dose, and whether resistance exercise is incorporated
Diabetes and pathogeneses of AD and PD The evidence linking diabetes to the increased risks of AD and PD underscores the complex mechanisms through which metabolic diseases influence brain health and function
Habegger KM, Heppner KM, Geary N, Bartness TJ, DiMarchi R, Tschp MH
Large-scale purification was conducted and the peptide 20GIPR/GLP-1RG s complexes were collected by SEC for cryo-EM studies, with all components of the complex identified in SDS-PAGE of the SEC peak (Supplementary Fig